PL371269A1 - Pochodne benzimidazolu podstawione grupą 1-fenylo-2-heteroarylową, ich zastosowanie do wytwarzania środków leczniczych do leczenia schorzeń immunologicznych - Google Patents

Pochodne benzimidazolu podstawione grupą 1-fenylo-2-heteroarylową, ich zastosowanie do wytwarzania środków leczniczych do leczenia schorzeń immunologicznych

Info

Publication number
PL371269A1
PL371269A1 PL03371269A PL37126903A PL371269A1 PL 371269 A1 PL371269 A1 PL 371269A1 PL 03371269 A PL03371269 A PL 03371269A PL 37126903 A PL37126903 A PL 37126903A PL 371269 A1 PL371269 A1 PL 371269A1
Authority
PL
Poland
Prior art keywords
heteroaryl
phenyl
treatment
drugs used
benzimidazole derivatives
Prior art date
Application number
PL03371269A
Other languages
English (en)
Other versions
PL216233B1 (pl
Inventor
Thorsten Blume
Wolfgang Halfbrodt
Joachim Kuhnke
Ursula Mönning
Bernd Elger
Herbert Schneider
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL371269A1 publication Critical patent/PL371269A1/pl
Publication of PL216233B1 publication Critical patent/PL216233B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL371269A 2002-02-15 2003-01-17 Pochodne benzimidazolu, ich zastosowanie oraz kompozycja farmaceutyczna je zawierająca PL216233B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10207844A DE10207844A1 (de) 2002-02-15 2002-02-15 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate

Publications (2)

Publication Number Publication Date
PL371269A1 true PL371269A1 (pl) 2005-06-13
PL216233B1 PL216233B1 (pl) 2014-03-31

Family

ID=27674913

Family Applications (1)

Application Number Title Priority Date Filing Date
PL371269A PL216233B1 (pl) 2002-02-15 2003-01-17 Pochodne benzimidazolu, ich zastosowanie oraz kompozycja farmaceutyczna je zawierająca

Country Status (30)

Country Link
EP (1) EP1474415B1 (pl)
JP (1) JP4739675B2 (pl)
KR (1) KR101027556B1 (pl)
CN (1) CN1317274C (pl)
AR (1) AR038492A1 (pl)
AT (1) ATE517881T1 (pl)
AU (1) AU2003205624B2 (pl)
BR (1) BR0307723A (pl)
CA (1) CA2475780C (pl)
CR (1) CR7442A (pl)
CY (1) CY1113230T1 (pl)
DE (1) DE10207844A1 (pl)
DK (1) DK1474415T3 (pl)
EC (1) ECSP045296A (pl)
ES (1) ES2369662T3 (pl)
IL (1) IL163431A (pl)
MX (1) MXPA04007949A (pl)
NO (1) NO329667B1 (pl)
NZ (1) NZ534660A (pl)
PE (1) PE20030941A1 (pl)
PL (1) PL216233B1 (pl)
PT (1) PT1474415E (pl)
RS (1) RS51831B (pl)
RU (1) RU2325384C2 (pl)
SI (1) SI1474415T1 (pl)
TW (1) TWI328583B (pl)
UA (1) UA81243C2 (pl)
UY (1) UY27661A1 (pl)
WO (1) WO2003068766A1 (pl)
ZA (1) ZA200407381B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039127A1 (es) 2002-03-27 2005-02-09 Glaxo Group Ltd Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
AU2004240649A1 (en) * 2003-05-19 2004-12-02 Irm, Llc Immunosuppressant compounds and compositions
WO2014044611A1 (en) 2012-09-20 2014-03-27 Bayer Pharma Aktiengesellschaft 1-aryl-2-heteroaryl benzimidazoles for the induction of neuronal regeneration

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
DK0520200T3 (da) * 1991-06-24 1998-09-23 Neurosearch As Imadazol-forbindelser, deres fremstilling og anvendelse
DE4129603A1 (de) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
NZ337749A (en) * 1997-05-01 2000-09-29 Nissan Chemical Ind Ltd Benzimidazole derivative and their use in allergy-related disease
EP1214330A1 (en) * 1999-09-21 2002-06-19 LION Bioscience AG Benzimidazole derivatives and combinatorial libraries thereof
IL150150A0 (en) 2000-01-14 2002-12-01 Schering Ag 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
US7115645B2 (en) * 2000-01-14 2006-10-03 Schering Aktiengesellschaft 1,2 diarylbenzimidazoles and their pharmaceutical use
DE10207843A1 (de) * 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen

Also Published As

Publication number Publication date
EP1474415B1 (de) 2011-07-27
AU2003205624A1 (en) 2003-09-04
CN1317274C (zh) 2007-05-23
WO2003068766A1 (de) 2003-08-21
EP1474415A1 (de) 2004-11-10
RS71404A (sr) 2006-10-27
RS51831B (sr) 2012-02-29
ZA200407381B (en) 2005-11-30
CR7442A (es) 2006-02-06
CA2475780C (en) 2011-08-02
ATE517881T1 (de) 2011-08-15
JP4739675B2 (ja) 2011-08-03
KR20040081795A (ko) 2004-09-22
DK1474415T3 (da) 2011-11-21
MXPA04007949A (es) 2004-11-26
KR101027556B1 (ko) 2011-04-06
RU2325384C2 (ru) 2008-05-27
PT1474415E (pt) 2011-10-13
AU2003205624B2 (en) 2009-08-27
NO20043841L (no) 2004-11-12
CA2475780A1 (en) 2003-08-21
ES2369662T3 (es) 2011-12-02
AR038492A1 (es) 2005-01-19
CY1113230T1 (el) 2016-04-13
IL163431A (en) 2010-11-30
NZ534660A (en) 2006-02-24
BR0307723A (pt) 2005-01-25
DE10207844A1 (de) 2003-09-04
TW200303307A (en) 2003-09-01
CN1633429A (zh) 2005-06-29
ECSP045296A (es) 2004-10-26
NO329667B1 (no) 2010-11-29
TWI328583B (en) 2010-08-11
PL216233B1 (pl) 2014-03-31
UY27661A1 (es) 2003-09-30
JP2005521686A (ja) 2005-07-21
UA81243C2 (en) 2007-12-25
RU2004127678A (ru) 2005-07-10
PE20030941A1 (es) 2004-01-17
SI1474415T1 (sl) 2011-12-30

Similar Documents

Publication Publication Date Title
IL163102A (en) Dihydrobenzodiazepin-2-one derivatives, process for their preparation and use thereof in the preparation of medicaments for the treatment of neurological disorders
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
IL189657A (en) Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
PT1656346E (pt) Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias
IL163725A0 (en) Administration of agents for the treatment of inflammation
AU2003216592A8 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
PL374118A1 (pl) Receptory interleukiny-1 w leczeniu chorób
PL377227A1 (pl) Postawione pochodne heksahydropirazyno [1,2-a] pirymidyno-4,7-dionu, sposób ich wytwarzania i ich zastosowanie jako środków leczniczych
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
IL214387A (en) History of tryptamine, method for their preparation and use for the preparation of pharmaceuticals and for the preparation of tryptamine
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
PT1487828E (pt) Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias
HRP20041157A2 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
IL156647A0 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
PL374858A1 (pl) Nowe pochodne aryloimidazolu, ich wytwarzanie i ich zastosowania terapeutyczne
PT1474415E (pt) Derivados de benzimidazol substituídos em 1-fenilo-2- heteroarilo, o seu uso para a produção de fármacos para o tratamento de doenças imunológicas
PL375309A1 (pl) Pochodne acyloksypirolidyny, ich wytwarzanie i ich zastosowanie lecznicze
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
AU2003294952A8 (en) 3,3-dimethyl-8-oxoisoquinolines for medical purposes, methods for the production thereof, medicaments containing said compounds and the use of the same
AU2003295504A8 (en) Development of therapeutics for the treatment of endotoxin-mediated diseases